Jim Dimitroulakos
Centre for Cancer Therapeutics
Ottawa Hospital Research Institute
501 Smyth Road
Ottawa
Canada
Name/email consistency: high
- Activating Transcription Factor 3 regulates in part the enhanced tumour cell cytotoxicity of the histone deacetylase inhibitor M344 and cisplatin in combination. St Germain, C., O'Brien, A., Dimitroulakos, J. Cancer Cell Int. (2010)
- Strategies to enhance epidermal growth factor inhibition: targeting the mevalonate pathway. Dimitroulakos, J., Lorimer, I.A., Goss, G. Clin. Cancer Res. (2006)